Adjuvant Effect of IV Clodronate on the Delay of Bone Metastasis in High-Risk Prostate Cancer Patients: A Prospective Study

PURPOSE: High-risk prostate cancer patients undergoing treatment often experience biochemical recurrence. The use of bisphosphonates as an adjuvant treatment delays skeletal events, yet whether or not bisphosphonates also delay metastastic development remains to be determined. MATERIALS AND METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodrigues, Paulo, Hering, Flavio O., Meller, Alex
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3253865/
https://www.ncbi.nlm.nih.gov/pubmed/22247708
http://dx.doi.org/10.4143/crt.2011.43.4.231

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3253865/
https://www.ncbi.nlm.nih.gov/pubmed/22247708
http://dx.doi.org/10.4143/crt.2011.43.4.231

Ejemplares similares